// App-Quantinova.ai

: Depletion rate of blood eosinophils with mepolizumab, benralizumab and oral prednisolone in patients with severe asthma

Researchers

Presenter

  • Angela Moran

Principal Investigators

  • Sanjay Ramakrishnan

  • Catherine Borg

  • Clare Connolly

  • Simon Couillard

  • Christine Mwasuku

  • Ian Pavord

  • Timothy Hinks

  • Lauri Lehtimӓki

Medical Centers

  • Department of Respiratory Medicine and NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust; Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom

  • Department of Respiratory Medicine and NIHR Oxford Biomedical Research Centre, Oxford University Hospitals NHS Foundation Trust; Nuffield Department of Clinical Medicine, University of Oxford; Allergy Centre, Tampere University Hospital and Tampere University, Tampere, Finland

Locations

  • United Kingdom

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Asthma

Biomarkers

  • N/A

Drug/Treatment

  • Benralizumab

  • Prednisolone

  • Mepolizumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved